- Home
- AMWL vs SCPH Comparison
AMWL vs SCPH Comparison
Compare AMWL & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- SCPH
- Stock Information
- Founded
- AMWL 2006
- SCPH 2013
- Country
- AMWL United States
- SCPH United States
- Employees
- AMWL N/A
- SCPH N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AMWL Technology
- SCPH Health Care
- Exchange
- AMWL Nasdaq
- SCPH Nasdaq
- Market Cap
- AMWL 110.6M
- SCPH 179.6M
- IPO Year
- AMWL 2020
- SCPH 2017
- Fundamental
- Price
- AMWL $7.98
- SCPH $3.38
- Analyst Decision
- AMWL Hold
- SCPH Strong Buy
- Analyst Count
- AMWL 4
- SCPH 2
- Target Price
- AMWL $12.50
- SCPH $15.00
- AVG Volume (30 Days)
- AMWL 63.4K
- SCPH 442.5K
- Earning Date
- AMWL 02-12-2025
- SCPH 11-13-2024
- Dividend Yield
- AMWL N/A
- SCPH N/A
- EPS Growth
- AMWL N/A
- SCPH N/A
- EPS
- AMWL N/A
- SCPH N/A
- Revenue
- AMWL $254,035,000.00
- SCPH $30,278,000.00
- Revenue This Year
- AMWL N/A
- SCPH $172.64
- Revenue Next Year
- AMWL $24.96
- SCPH $131.43
- P/E Ratio
- AMWL N/A
- SCPH N/A
- Revenue Growth
- AMWL N/A
- SCPH 303.87
- 52 Week Low
- AMWL $5.00
- SCPH $3.08
- 52 Week High
- AMWL $29.00
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- AMWL 49.32
- SCPH 44.62
- Support Level
- AMWL $7.02
- SCPH $3.27
- Resistance Level
- AMWL $8.83
- SCPH $3.58
- Average True Range (ATR)
- AMWL 0.47
- SCPH 0.19
- MACD
- AMWL 0.09
- SCPH 0.01
- Stochastic Oscillator
- AMWL 53.04
- SCPH 22.92
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.